New York City, NY -- (SBWIRE) -- 04/21/2017 -- Centrifugation is the process which involves the separation of heterogeneous mixture by means of spinning and this involves the application of centripetal force for the separation of liquids-liquid and liquid-solid mixtures. Centrifugation works on the principle of sedimentation that can be achieved by rapid rotation. Centrifuges are the devices which are used in separation of genetic materials, virulent substances, blood cell components, and others. The next generation centrifuges provides precise temperature control, wide range of relative centrifugal force (RCF), acceleration, and time. All the aforementioned parameters must be maintained and achieved for greater separation of quality components. The next generation centrifuges have feature such microprocessors helps to achieve above parameters very precisely, frequency drive motor for smooth operation and internal memory to store programs which helps in getting quality result with single button operation. Next generation centrifuges allows network and PC connectivity which helps in data management, apart from these features, next generation centrifuges enhances the sample quality, reduce laboratory turnaround time, improve laboratory efficiency and energy efficient. Next generation centrifuges revolutionized the yield of tissue, cell components and standardized the good quality cells or components every time the sample is processed
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11644
Next generation centrifuge market is continue to witness significant growth owing to increased demand for newer technologies for cell and cell component separation in laboratory practice and growing usage in biopharmaceutical and pharmaceutical companies for biological products manufacturing and development. Apart from this rising demand for higher volume, higher speed, higher throughput centrifuges from research institutes and academia, increased infectious and chronic diseases, technological advancement and government's investment in research and development will help to bolster next generation centrifuge market over the forecast period. However lack of skilled professionals to operate these advanced centrifuges, availability of alternative downstream processing techniques such as membrane filtration which improves the yield can replace centrifugation for its reduced maintenance and labor cost, and size of the centrifuge instruments may hamper the growth of next generation centrifuge market over the forecast period.
Global next generation centrifuge market is experiencing significant growth owing to increased demand for advanced centrifuges in various academic institutes, research centers and biopharmaceutical companies. Increased usage of next generation centrifuges in place of conventional centrifuges and, instruments high and quality yield may positively impact the next generation centrifuge market dynamics over a given period of forecast. Moreover recent development of newer technologies in centrifuge accessories such as tubes and filters and presence of international players in the centrifuge market may help grow this market significantly.
Geographically next generation centrifuge market is classified into regions viz. North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America and Europe will remain key markets for next generation centrifuge market due to extensive research and development activities in both public and private sector, government's key initiatives in science and technology and presence of key players in the market. Asia Pacific is anticipated to register positive growth owing to rising government's investment in life science sector and expanding biopharmaceutical industry in the region
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/11644
Some of the key players in the next generation centrifuge market are QIAGEN, Thermo Fisher Scientific Inc., Eppendorf AG., Siemens Healthcare GmbH, Beckman Coulter, Inc., Labnet International, Inc., BD Biosciences, Danaher Corporation, to name a few.